Rapid and large-scale implementation of HCV treatment advances in France, 2007-2015.

Cécile BrouardMarjorie Boussac-ZarebskaChristine SilvainJulien DurandVictor de LédinghenJosiane PillonelElisabeth Delarocque-Astagneau

Published in: BMC infectious diseases (2017)

Successive advances in HCV treatment have been rapidly and widely implemented in France. With the announcement of universal access to DAAs in mid-2016 and price reductions, access to 2nd-wave DAAs is expected to expand even more.

Keyphrases

hepatitis c virus
primary care
healthcare
quality improvement